DHG Pharmaceutical JSC Capital Reinvestment Ratio
DHG Pharmaceutical JSC capital reinvestment ratio. DHG Pharmaceutical JSC (DHG) has a Capital Reinvestment Ratio of 0.20x as of June 2026, meaning it reinvests 0% of its operating cash flow (₫214.23 Billion) in capital expenditures (₫42.28 Billion). Check DHG cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of DHG Pharmaceutical JSC (2019–2025)
Capital reinvestment ratio of DHG Pharmaceutical JSC from 2019 to 2025. This chart tracks DHG Pharmaceutical JSC's Capital Reinvestment Ratio across 7 annual periods. Also explore net asset growth rate of DHG Pharmaceutical JSC to track the company's year-over-year net asset growth rate.
DHG Pharmaceutical JSC Capital Reinvestment Ratio by Year (2019–2025)
DHG Pharmaceutical JSC capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see DHG cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | ₫1.21 Trillion | ₫31.14 Billion | ▼ -61.9% |
| 2024 | 0.07x | ₫1.32 Trillion | ₫88.70 Billion | ▼ -95.6% |
| 2023 | 1.55x | ₫279.88 Billion | ₫432.73 Billion | ▲ +495.5% |
| 2022 | 0.26x | ₫901.28 Billion | ₫233.99 Billion | ▲ +378.2% |
| 2021 | 0.05x | ₫452.44 Billion | ₫24.56 Billion | ▼ -49.5% |
| 2020 | 0.11x | ₫826.17 Billion | ₫88.81 Billion | ▲ +57.8% |
| 2019 | 0.07x | ₫838.24 Billion | ₫57.10 Billion | — |